Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1995-3-2
pubmed:abstractText
We have developed a new micromethod to study the effect of drugs on microsporidia, using MRC5 fibroblasts infected by 10(5) spores of Encephalitozoon cuniculi. After 3 days of incubation with various concentrations of drugs, parasitic foci were counted in stained cultures. The inhibition of microsporidial growth exceeding 90% with albendazole (0.005 microgram/ml), fumagillin (0.001 microgram/ml), 5-fluorouracil (3 micrograms/ml), and sparfloxacin (30 micrograms/ml) was observed. Chloroquine, pefloxacin, azithromycin, and rifabutin were partially effective, at high concentrations. Arprinocid, metronidazole, minocycline, doxycycline, itraconazole, and difluoromethylornithine were not evaluable, since concentrations that inhibited microsporidia were also toxic for fibroblasts. Pyrimethamine, piritrexim, sulfonamides, paromomycin, roxithromycin, atovaquone, and flucytosine were ineffective. Our results confirm that albendazole and fumagillin have marked activity against E. cuniculi and show the antimicrosporidial activity of 5-fluorouracil and sparfloxacin. These data may form the basis for treatment of Encephalitozoon hellem and Septata intestinalis infections and represent an attempt to identify drugs effective against Enterocytozoon bieneusi.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-109602, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-121934, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1480605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1567576, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1607196, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1614329, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1779288, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1818210, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1848925, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1903878, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1904839, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1920150, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-1995733, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-2319490, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-2505609, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-2656050, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-3109297, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-3121760, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-3486233, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-3770064, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-465283, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-6606682, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-6772772, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-739413, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8117342, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8228321, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8263205, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8277179, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8278216, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8287631, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8292991, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8308313, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8389641, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8418171, http://linkedlifedata.com/resource/pubmed/commentcorrection/7840584-8457797
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2440-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi.
pubmed:affiliation
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Paris, France.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't